Michael Mc Hugh
About Michael Mc Hugh
Michael Mc Hugh is the Senior Manager of Cell Therapy Finance at Bristol Myers Squibb, with over 30 years of experience in finance and supply chain management within the pharmaceutical industry.
Company
Michael Mc Hugh is currently serving as the Senior Manager, Cell Therapy Finance at Bristol Myers Squibb. This position is based in Summit, New Jersey, United States. Bristol Myers Squibb is a global leader in the pharmaceutical industry, known for its innovative therapies and commitment to improving patient outcomes.
Title
Michael Mc Hugh holds the title of Senior Manager, Cell Therapy Finance. His role involves financial management within the cell therapy division, contributing to the company's financial stability and strategic growth in this cutting-edge field.
Career at Celgene
Michael Mc Hugh had various roles at Celgene from 2006 to 2020. He started as a Manager, Cost Accounting, and transitioned through several positions including Manager, Global Supply Chain Master Data, Senior Manager, Global Supply Chain Master Data, and finally, Senior Manager, Global Inventory Control. His diverse roles at Celgene underscore his versatility and expertise in finance and supply chain management.
Experience at Par Pharmaceutical
Before joining Celgene, Michael Mc Hugh worked at Par Pharmaceutical as the Associate Director, Finance, for a decade from 1996 to 2006. This long tenure allowed him to develop substantial expertise in financial management within the pharmaceutical industry.
Education and Expertise
Michael Mc Hugh earned his Bachelor's degree in Accounting and Computer Science at Montclair State University, where he also obtained a Bachelor of Science in Accounting. This academic foundation, combined with over 30 years of professional experience in finance and supply chain management, establishes his deep expertise in the field.
Early Career at Emerson Radio
Michael Mc Hugh began his professional journey at Emerson Radio, where he served as a Senior Accountant from 1988 to 1996. During his 8-year tenure, he gained foundational experience in accounting that set the stage for his future roles in the pharmaceutical industry.